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Apoptosis is a physiological cell death process essential for development, tissue homeo-
stasis, and for immune defense of multicellular animals. Inhibitors of apoptosis proteins 
(IAPs) regulate apoptosis in response to various cellular assaults. Using both genetic 
and pharmacological approaches we demonstrate here that the IAPs not only support 
opportunistic survival of intracellular human pathogens like Chlamydia pneumoniae but 
also control plasticity of iNOS+ M1 macrophage during the course of infection and 
render them refractory for immune stimulation. Treatment of Th1 primed macrophages 
with birinapant (IAP-specific antagonist) inhibited NO generation and relevant proteins 
involved in innate immune signaling. Accordingly, birinapant promoted hypoxia, angio-
genesis, and tumor-induced M2 polarization of iNOS+ M1 macrophages. Interestingly, 
birinapant-driven changes in immune signaling were accompanied with changes in the 
expression of various proteins involved in the metabolism, and thus revealing the new 
role of IAPs in immune metabolic reprogramming in committed macrophages. Taken 
together, our study reveals the significance of IAP targeting approaches (Smac mimetic 
compounds) for the management of infectious and inflammatory diseases relying on 
macrophage plasticity.
Keywords: apoptosis, macrophages immunobiology, inflammation mediators, polarization, infection, 
hypothalamus
inTrODUcTiOn
Deregulated host cell apoptosis leads to destructive inflammatory responses which are deleterious 
in nature as seen in septic shock, auto-immunity, cancer, and episode of chronic bacterial infec-
tions. Resistance to apoptosis relies on the increased expression and stability of anti-apoptotic 
proteins namely inhibitors of apoptosis proteins (IAPs). Chlamydia pneumoniae, a Gram-negative 
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obligate intracellular human pathogen which is associated with 
many chronic inflammatory diseases (1) including chronic 
obstructive pulmonary disorders, chronic heart disease, 
asthma, and other idiopathic diseases (2–4), exploits host 
apoptosis pathways to escape eradication by immune effec-
tor cells (6, 7). Among all the cells with which these bacteria 
interact macrophages have gained particular importance, for 
their role in bacterial clearance and for acting as bacterial car-
riers during persistency. During acute infection, iNOS+ and 
pro-inflammatory macrophages are sufficient to clear off the 
infection from the lungs (8, 9). However, under chronic disease 
conditions such as bacterial persistency, particularly in the case 
of C. pneumoniae infection, inflammation can lead to vascular 
remodeling and tumor-like phenotype in the infected area, 
which is manifested by polarization of M1 effector macrophages 
toward M2 or refractory macrophages. It is anticipated that this 
mechanism could be decisive for neoplastic transformation of 
infected tissue and thus leading to the development of lung 
adenocarcinoma. We have previously shown that deregulated 
host cell apoptosis in C.  pneumoniae-infected IAP-deficient 
mice helps these bacteria to replicate more efficiently as a result 
of weak immune response of macrophages and T cells (10, 11). 
In line with our previous data, here we demonstrate that IAPs 
are important for the phenotypical and functional plasticity of 
macrophages during the course of C. pneumoniae pulmonary 
infection. Furthermore, we also demonstrate here that targeting 
IAPs pharmacologically by Smac mimetic-based approaches 
(12, 13) led to metabolic programming of iNOS+ macrophages 
and enhancement of non-immunogenic and sterile inflamma-
tory response in Th1-primed iNOS+. Altogether, our results 
provide new regulatory role of IAPs in immune-metabolic 
reprogramming and phenotypical plasticity of committed/




The general reagents were purchased from Sigma-Aldrich 
(UK), unless stated otherwise. RPMI 1640, lipopolysaccharide 
(LPS), Gentamicin, MTT and NaNO2, sodium nitroprusside 
(SNP), penicillin–streptomycin solution, and metformin were 
procured from Sigma-Aldrich. Recombinant mouse IFNγ 
cytokine is from eBiosciences (San Diego, CA, USA). CD11b+ 
human and Mouse MACS Microbeads and LC Columns are 
from Miltenyi Biotec. Primary antibodies including rabbit poly-
clonal NOS-2, rabbit polyclonal xIAP, cIAP-1, cIAP-2, LAMP-2, 
CD-206, rabbit polyclonal β-actin, and mouse monoclonal 
β-actin are from Santa Cruz biotechnology. Mouse monoclonal 
arginase-1 is from BD Biosciences. Rabbit monoclonal STAT1 
and 3, pp38MAPK, and pNF-kB p65 are from Cell Signalling 
Technology. Ym-1 antibody was purchased from Stem cell 
technologies; Fizz-1 antibody was from Abcam. HRP-linked 
anti-mouse IgG and anti-rabbit IgG are from Cell Signalling 
Technology. TNFα and IL-10 ELISA kits were purchased from 
R&D system (Darmstadt, Germany).
cell lines, cell isolation, and cell 
culture
Standard murine macrophage cell line RAW264.7A, procured 
from ATCC, was cultured in RPMI 1640 medium containing 
2  mM l-glutamine supplemented with 10% FCS, 100 IU/ml 
penicillin, and 100  µg/ml streptomycin. Both wild-type and 
well-described Ciap-1 knockdown He La cells (14, 15) were 
cultured in DMEM medium supplemented with 10% serum 
and antibiotics. Mouse peritoneal macrophages were elicited 
by 4% Brewer’s thioglycolate medium and purified by MACS 
bead-based method (Miltenyi Biotec). Briefly, C57BL/6j mice 
were injected with 4% Brewer’s thioglycolate medium (Fluka, 
Sigma-Aldrich) into the peritoneal cavity. Peritoneal exudates 
were obtained 72 h after injection by flushing the peritoneal cav-
ity with ice-cold serum-free RPMI 1640 medium using a 22 G 
needle. Peritoneal lavage was pooled and centrifuged in a 50-ml 
conical centrifuge tube at 1,500 rpm for 10 min at 4°C, and the 
pellet was resuspended in RPMI 1640 medium supplemented 
with 10% heat-inactivated fetal calf serum, 15  mM HEPES 
buffer, and 2 mM l-glutamine. Macrophages from mice lungs 
were excised aseptically and digested for 1 h with collagenase 
containing RPMI 1640 medium. The digested lung tissues were 
gently mashed, and homogenates were prepared. RBCs in the 
tissue homogenates were lysed by RBC lysing buffer. Cells were 
washed with excess of serum-free RPMI medium. Primary 
blood mononuclear cells were isolated from citrated blood of 
healthy volunteers, following informed consent by the ficoll-
based separation method. Monocytes were allowed to adhere 
to tissue culture wells (24-well plates) for 1 h prior to removal 
of other cells by washing with serum-free RPMI. Isolated 
monocytes were cultured for 7–8 days in a macrophage-SFM 
medium (Invitrogen Corp., Paisley, UK) at 37°C in a 5% CO2 
incubator. The CD11b+ Gr-1 (−) macrophages from lung and 
peritoneal lavage from mice and PBMC from healthy donors 
were purified with CD11b+ Miltenyi micro beads, and the cells 
were FACS sorted for CD11b+ and Gr-1-negative population. 
Cells were counted and checked for viability by the trypan 
blue dye exclusion method. Cells were cultured at 2.5 ×  104 
cells per well in a final volume of 200 µl in flat-bottom 96-well 
plate and incubated 0/N for adhesion at 37°C in a humidified 
environment at 5% CO2. Non-adherent cells were removed 
by washing with serum-free RPMI 1640 medium. Cells were 
stimulated with either LPS (1 µg/ml), IFNγ (50 ng/ml), or both 
(LPS + IFNγ) as needed.
Chlamydia pneumoniae Stock
Chlamydia pneumoniae strain VR1310 was propagated in HEp-2 
cells. These cells were infected with C. pneumoniae and lysed by 
mechanical disruption with a rubber policeman 72-h post infec-
tion. Bacteria were subsequently harvested by centrifugation at 
500 × g at 4°C for 10 min. The pellet was ruptured using glass 
beads, and the lysates were centrifuged as before. The superna-
tants were removed and centrifuged at 45,000 × g for 45 min at 
4°C in a SS34 rotor (Sorvall Instruments) to pellet Chlamydia. 
The bacteria were resuspended in sucrose phosphate glutamate 
buffer and stored at −80°C.
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animal experiments
WT C57BL/6, XIAP (B6.129X1-Birc4 tm1 Thsn/Hsd), and 
cIAP-1 knockout mice were used in this study. These mice were 
infected with C. pneumoniae serovar TW1310 by a non-invasive 
aerosol method as described earlier (10, 11). The mice were kept 
in S-2 animal house facility for a period of 20  days. The mice 
were sacrificed by cervical dislocation and whole lung tissue was 
harvested and analyzed for various M1 and M2 effector proteins 
by Western analysis. All animal experiments were performed 
as per the guidelines laid down and approved by Institutional 
Animal ethical committee approval (UH/IAEC/HP/2014-I/21).
Microbial infection
Chlamydia pneumoniae was propagated and cultivated in Hep2 
as described. Mouse macrophages and epithelial cells were 
infected with C. pneumoniae at MOI-1 in RPMI medium contain-
ing 5% FCS. Cells were centrifuged at 700 × g for 1 h at RT for 
infection. After centrifugation, the cells were incubated for 1 h in 
a CO2 incubator at 37°C. After 1 h incubation period, the medium 
was replaced with RPMI containing 5% FCS, 1% Gentamicin, and 
1  µg/µl of cycloheximide. The cultures were incubated further 
for different time intervals at 37°C in a CO2 incubator at 95% 
humidity. Glycerol stock of Ms was revived in Middle-brook 
7H9 medium supplemented with 10% FBS and 0.2% glycerol 
and incubated at 37°C. Escherichia coli (Ec) was cultured in Luria 
broth at 37°C while Leishmania donovani (Ld) was cultured in 
RPMI medium containing 10% FBS and incubated at 25°C. All 
the cultures were periodically passaged. RAW macrophages were 
seeded in 24-well tissue culture plates (0.2 × 106/well) and incu-
bated overnight in a CO2 incubator at 37°C. Next day morning 
macrophages were infected with log phage cultures of Ms and Ec 
at MOI-10 and Ld at MOI-5. Before infection, bacterial clumps in 
Ms culture were removed by passing culture through 25G needle 
15–20 times. After an hour of infection extracellular bacteria were 
removed by washing thrice with PBS, and then respective treat-
ments were given with IFNγ (50 ng/ml), birinapant (60 µM), and 
combination of IFNγ and birinapant in RPMI medium (without 
FBS) containing Gentamicin (10 mg/ml). In the case of Ld infec-
tion, macrophages were infected for 6  h, and then subsequent 
treatments were given as described above. The cells were incu-
bated further in a CO2 incubator and at different time intervals, 
cell culture supernatants for NO quantification and cell lysates 
for Western blot analysis of various proteins were collected. To 
demonstrate bacterial killing by macrophages, bacterial counts 
were performed over a time period of 48 h. For this purpose, cell 
lysates were serially diluted in sterile PBS and different dilutions 
plated over Middle-brook 7H10 agar plates for Ms and Luria agar 
plates for Ec. The bacterial colonies were counted after 3–5 days, 
and bacterial number was documented as colony forming units 
per milliliter.
Macrophage Polarization assay
RAW macrophages were cultured in complete RPMI medium at 
2.5 × 104 per well in 96-well plates for 24 h at 37°C. Spent medium 
in each well was replaced with fresh culture medium containing 
hypoxia inducer (CoCl2), angiogenic stimuli [vascular endothelial 
growth factor (VEGF)], and PancO2 tumor lysate, respectively, 
with and without birinapant and indicated Th1 stimuli.
nO Production and Quantification
Nitric oxide production was quantified in macrophage culture 
supernatants through the standard Griess reagent method. 
Briefly, equal volumes of the culture supernatants and Griess 
reagent [1% sulfanilamide/0.1% N-(naphthyl) ethylenediamine 
dihydrochloride prepared in 5% o-phosphoric acid] were mixed 
and incubated for color development. Absorbance was measured 
at 550 nm using a Spectra max spectrometer (Molecular Devices 
ORT), and NO titers in samples were quantified against a NaNO2 
standard curve generated using software provided with the 
Spectra max spectrometer (Molecular Devices).
Western Blotting
CD11b+ Gr-1 (−) mouse pulmonary macrophages or lung 
tissues were lysed in RIPA buffer (50  mM Tris-HCl, pH 7.4, 
150  mM NaCl, 2  mM EDTA, 1% Nonidet P-40, and protease 
inhibitor mixture) and sonicated. The lysate was centrifuged at 
14,000 rpm for 20 min at 4°C to separate the particulate fraction. 
Protein concentration was determined by BCA kit (Peirce). 20 µg 
of proteins/group was separated on Nu-PAGE gradient gel and 
blotted on a PVDF membrane by wet electroblotting. Blots were 
blocked with 5% non-fat dry milk in TBS-T at pH 7.5 (20 mM 
Tris base, 137 mM NaCl, and 0.1% Tween 20) and then incubated 
over night at 4°C with primary antibodies followed by the HRP 
conjugated secondary antibody. For in vitro experiments, 1 × 106 
RAW macrophages from each experimental group were lysed, 
and proteins were prepared and analyzed for various signaling 
parameters by the Immunoblot method. For ex vivo stimulation 
experiments 1 × 106 macrophages per well were used, while for 
infection experiments 1 × 104 macrophages were used. Blots were 
developed by ECL reagent (Amersham Life Sciences), and actin 
was used as a loading control for normalization. The Western 
blots were quantified for densitometry by Image J software, and 
mean densitometry value of independent protein was divided 
with its mean densitometry value of its respective β-actin band 
intensity value to present the relative expression of each protein 
as a mean in the ratio of protein to actin.
immunofluorescence staining
Cells cultured on glass cover slips were fixed with 4% PFA for 
15 min and permeabilized by PBS-TritonX-100 (0.1%) for 5 min 
and blocked with TBS + 1% BSA + 1% sera from species of the 
respective secondary antibodies. After two washes with PBS, 
cells were incubated with primary antibodies overnight at 4°C 
followed by incubation of cells with respective secondary anti-
bodies (Alexa Fluor-488 for green and -569 for red color) for 
1 h. Nuclei were stained with DAPI for 5 min. Stained cells were 
washed, mounted on glass slides, and analyzed using a fluorescent 
microscope (Axivort, Carl Zeiss) under 63× magnification.
Metabolic activity analysis
The MTT reduction assay is used to determine the level of meta-
bolic activity in macrophages which relies on the reduction of 
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MTT, a yellow water-soluble tetrazolium dye, primarily by the 
mitochondrial dehydrogenases, to purple colored formazan crys-
tals. The formazan product is analyzed spectrophotometrically 
(550  nm) after dissolution in DMSO. Obtained OD values for 
control samples were normalized to 100%, and the difference in 
the metabolic activity of treated samples compared to control 
samples was analyzed.
elisa
Pulmonary titer of IL-10 in WT and xIAP KO mice both infected 
and uninfected and release of TNF in IFNγ-induced iNOS+ 
macrophages from both WT and xIAP KO were analyzed 
by sandwich ELISA according to instruction manual from 
manufacturer (R&D system). Similarly, soluble/shed TNFR1 
(sTNFR1) in cell culture supernatants of cIAP1 shRNA transfected 
and vector control stable HeLa cell clones were infected with 
C. pneumoniae for one infection cycle were analyzed by ELISA 
according to the manufacturer’s instructions (BIOSOURCE).
Wound healing assay
HeLa cells were grown in complete RPMI medium at 2.5 × 104  
per well in 24-well plates for 24 h at 37°C to form a cell monolayer 
before the wound was made by a scratch. Spent medium in each 
well was replaced with either fresh culture medium or conditioned 
medium by primary macrophages stimulated and treated with 
and without BP. The cells were cultured for another 24 h with and 
without BP, CoCl2, and VEGF, respectively. Images of the wound 
areas were taken by using an Inverted Fluorescence Microscope 
(IX73; Olympus Corporation, Japan) at 10× and compared with 
the images taken immediately after scratch was made. The wound 
areas were measured using the ImageJ software, and the percent-
age closure of the wound area was represented as mean ± SE from 
three independent experiments.
global gene expression analysis
Both cIap1 WT and KO macrophages were purified and stimu-
lated with TNF for 24  h duration. mRNA was extracted from 
these cells, purified and then analyzed by whole mouse genome 
44k microarray Kit (Agilent technology Cat No: G4122F, Chip ID 
no: 014868) various genes that were analyzed by Pathway Tools 
version 15.0, MetaCyc version 15.0. Onto-Tools1 Pathway Express 
was used to map differentially expressed genes, and Gene Spring 
12.6.1 software (Agilent Technologies, Santa Clara, CA, USA) 
was used to prepare corresponding heat map. Pathways that were 
up/downregulated during TNF induction and/or CIAP-KO were 
identified using the previously developed method on Gene-Set 
enrichment analysis (16). Genessets for mouse were downloaded 
from Bader lab.2 The Gene sets were obtained by translation 
of human counterparts using orthologous relationship from 
homologene database. The Gene sets consist of pathways from 
PID, Reactome, Panther pathways, and gene ontology process 
from Mouse Genome Database. The data set was submitted to 
GEO website, and accession number of the same was obtained, 




PathScan Intracellular Signaling Array Kit was purchased from 
Cell Signaling Technology (Cell Signaling Technology, #7323). 
Whole cell lysates of naive and IFNγ stimulated macrophages 
with and without birinapant under both infectious and sterile 
inflammatory conditions were prepared using lysis buffer 
provided in the kit. 100  µl of each lysates was placed onto 
the membrane window of the antibody array-slide. The lysate 
treated slide was incubated overnight at 4°C on an orbital 
shaker. The slide was then washed with 100 µl 1× array wash 
buffer and incubated on the orbital shaker for 5 min at room 
temperature. This procedure was repeated three more times. 
75  µl of 1× detection antibody cocktail was added to each of 
the 16 wells and covered with a sealing tape provided in the kit 
and incubated for 1 h at room temperature on an orbital shaker. 
Following three washes with 1× array wash buffer, the slide was 
incubated for 30 min with 75 µl 1× HRP-linked Streptavidin. 
The slide was washed and treated with LumiGlo and peroxide. 
The Bio-rad Gel Documentation System was used to take 
detailed pictures of the array. Images were analyzed by using 
ImageJ software, and mean densitometry values were plotted in 
terms of relative expression.
statistical analysis
Data indicate mean  ±  SEM of representative experiments. 
Statistical significance was calculated by two-tailed unpaired 
t test for two data sets and two-way ANOVA followed by the 
Bonferroni test was used for multiple group comparisons 
(*p < 0.05; **p < 0.01; and ***p < 0.001).
resUlTs
iaPs control M1 Polarization of 
Macrophages during Bacterial infection
ciap1 (11) and Xiap (10) KO mice failed to clear C. pneumoniae in 
spite of having high titers of IFNγ and TNFα which could be due 
to enhanced pulmonary titer of IL-10 in these mice (Figures 1A) 
over WT counterpart indicating Th2 biased immune response 
in XIAP-deficient mice. To further substantiate this, several M1 
and M2 markers including STAT-1 and 3 (17), Ym-1, Fizz-1 
and Arginase-1 (18, 19) in whole lung homogenates as well 
as in the purified CD11b+/Gr-1 (−) pulmonary macrophages 
from WT and xIAP KO mice were analyzed. Western blot 
analysis of infected XIAP KO lung (Figures 1B,C) and purified 
CD11b+/Gr-1 (−) pulmonary macrophages (Figures  1D,E) 
revealed downregulation of phospho-STAT-1 and upregulation 
of Ym-1 and Fizz-1 proteins in XIAP KO mice demonstrat-
ing M2/Th2-rich environment. Increase in the expression of 
chlamydial HSP60, whose expression was shown to be greatly 
enhanced in chlamydia infection and major outer membrane 
protein (an immunodominant surface antigen) in the lung of 
XIAP KO-infected mice was observed suggesting their possible 
involvement in promoting macrophage polarization (Figure 1F). 
Interestingly, reduced expression of phospho-STAT-1 proteins 
revealed IFNγ signaling defects in XIAP KO mice (17, 20). 






FigUre 1 | Continued
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FigUre 1 | XIAP deficiency promotes M2 polarization during the course of infection. (a) Pulmonary titer of IL-10 in xIAP KO mice and its WT counterpart at 
20th post infection day was analyzed by sandwich ELISA. (B–e) Whole lung tissue and CD11b+/Gr-1 (−) pulmonary macrophage cell lysates from both WT and 
Xiap KO mice 20 days after Chlamydia pneumoniae infection were analyzed by Western blotting for M1 and M2 signaling markers. (F) Expression of chlamydial 
HSP60 and major outer membrane proteins in the lung of XIAP KO-infected mice with time and (g) expression of iNOS protein in XIAP-deficient CD11b+/Gr-1 
(−) pulmonary macrophages over WT counterpart in response to TNF stimulation were analyzed by Western blotting. 20 µg of protein per sample was analyzed  
by the immunoblot method as described in the “Materials and Methods” section. β-actin was used as a loading control. Representative blots from three 
independent mice infections with similar outcome are shown. The Western blots were quantified for densitometry by Image J software, and mean densitometry 
values of independent proteins were divided with its mean densitometry values of its respective β-actin band intensity value to present the relative expression of 
each protein as a mean in the ratio of protein to actin. Data shown here is the ±SEM from three independent experiments. Statistical analysis was conducted 
either by using two-tailed unpaired t-test and/or by using two-way ANOVA followed by Bonferroni post-test, respectively (*p < 0.05; **p < 0.01; and 
***p < 0.001).
6
Nadella et al. IAPs Control Macrophage Polarization and Immune-Metabolism
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 8 | Article 1792
Gr-1 (−) pulmonary macrophages over WT counterpart, in 
response to TNF stimulation (Figure 1G) revealing the impor-
tance of XIAPs in TNF-mediated skewing of M1 phenotype in 
these macrophages while explaining in part the redundancy of 
albeit high TNF in these mice. In similar lines, reduction in the 
expression of LAMP-2 proteins was evident in both infected 
XIAP KO lungs and in pulmonary macrophages (Figures 1C,D), 
and this could be due to strategic depletion of acidic lysosomes 
in host cells by these bacteria for adapting to hostile environment 
of XIAP-deficient macrophages (21).
Upregulation of cIAP proteins and reduced expression of 
XIAP proteins during the course of infection (11) revealed a 
possible compensation of IAP proteins in ciap-1 KO animals. 
However, XIAP proteins remained redundant in controlling 
cIAP-1 proteins in XIAP KO macrophages and lung. Therefore, 
we anticipated cIAP-1 dependent regulation of TNF response 
in both cIAP-1 and XIAP KO macrophages. To that purpose, 
global gene expression analysis was performed in purified 
CD11b+/Gr-1 (−) peripheral macrophages from WT and ciap1 
KO mice. In line with our previous observation, microarray 
data (Accession Nr: GSE106451) revealed the upregulation 
of genes responsible for angiogenesis and downregulation 
of genes responsible for immune, anti-microbial response in 
cIAP1 KO macrophages over WT counterpart (Figures S1A–E 
in Supplementary Material; Table 1A,B). Most interestingly, the 
ciap1 deletion resulted in upregulation of IL-5, NOS1, VEGF, 
and TAK1 and PPARG genes in response to TNF, all of which 
are associated with M2 immune responses indicating the sen-
sitization of IAP-deficient mice for infection and macrophages 
for M2 polarization.
iaP Deficiency renders infected 
Macrophages refractory for immune 
stimulation
Macrophages are double edge components of the innate immune 
system and promote adaptive immune response for the clearance 
of infection on one hand while being responsible for various 
infection-related idiopathic disorders mainly during bacterial 
persistency on the other. Chlamydia containing endosomes 
in foamy macrophages in coronary atheroma patients clearly 
demonstrate the dichotomy of macrophage behavior during 
persistent infection which was defined to be due to polarization 
of these regulatory macrophages toward refractory/patrolling/
foamy phenotype by these bacteria for their survival (22). To 
address this, IL-10 titers in both C. pneumoniae-infected WT 
and XIAP−/− mice were analyzed. Increased pulmonary titer 
of IL-10 in infected mice (Figure  2A) clearly revealed Th2 
programming of immune response by these viable bacteria. 
In vitro data with C. pneumoniae-infected CD11b+/Gr-1 (−) 
peripheral macrophages also demonstrated a significant inhibi-
tion of NO generation upon IFNγ induction (Figure 2B) and 
release of TNF in IFNγ-iNOS+ macrophages (Figures  2C,D) 
clearly demonstrating the loss of Th1 programming in these 
infected macrophages. IL-10 expression has also shown to 
inhibit IFNγ-dependent NO production by macrophages and 
thereby their ability to control parasitic infections (23). In simi-
lar lines, these bacteria also abolished TNF-induced generation 
of NO in iNOS+ macrophages (Figures  2E,F). Induction of 
spontaneous shedding of sTNFR1 in their culture supernatants 
of Chlamydia-infected epithelium (Figure S2 in Supplementary 
Material) demonstrated the sabotage of TNF response by 
these bacteria. Most interestingly, IAP-deficient macrophages 
remained more refractory over WT-infected macrophages 
indicating the dependency of macrophages on IAP proteins for 
immune restoration (Figures 2G,H). Chlamydia infection not 
only inhibited the immune mediated activation of macrophages, 
but also abolished sodium nitroprusside (SNP)-induced release 
of NO in these macrophages (Figures S3A,B in Supplementary 
Material) which is most likely due to chelation of Fe+++ to Fe++ 
by these bacteria which promote bacterial persistency. Thus, 
these data, in support of our hypothesis, provided experimental 
evidence that these bacteria are capable of rendering infected 
macrophages refractory to immune-mediated stimulation 
during persistent phase. C. pneumoniae infection alone or in 
combination with Th1 effector cytokines could not enhance 
Caspase-3 levels in macrophages (11), suggesting that apop-
tosis in these macrophages may not have accounted for M2 
polarization of infected macrophages. To further elucidate 
the reason of this interference, we analyzed the mitochon-
drial activities which are known to have an impact on iNOS 
proteins and their active involvement in anti-bacterial defense 
of infected macrophages (24). Standing in line with NO and 
TNF data, complete or significant reduction in the metabolic 
activities (25) of both naïve as well as Th1-primed M1 or SNP - 
treated macrophages by C. pneumoniae (Figures S4A–D in 
Supplementary Material) was evident suggesting dysregulation 
of mitochondrial functions by these bacteria. This could be a 
TaBle 1 | Global gene expression analysis by microarray in purified CD11b+/Gr-1 (‒) peripheral macrophages from WT and ciap1 KO mice.
(a) ciaP1-KO Vs WT (naive)
Upregulated Downregulated
TNFR2, INTRINSIC, NO1, VIP, 41BB, TNFR2, ACH, and NKT PYK2, IL1R, MAL, MITOCHONDRIA, HCMV, IL17, RAS, 
NEUROTRANSMITTERS, ERYTH, HER2, HCMV, BARR_MAPK, FAS, SARS,  
and GLYCOLYSIS
Positive regulation of ER associated ubiquitin-dependent protein catabolic
Regulation of receptor internalization
Cranial nerve formation
Peptidyl asparagine modification
Regulation of cholesterol esterification
Positive regulation of cholesterol esterification
Protein N-linked glycosylation via asparagine
Cranial nerve formation
Negative regulation of retrograde protein transport ER to cytosol
Negative regulation of protein exit from endoplasmic reticulum
Positive regulation of regulatory T cell differentiation
Regulation of NFAT protein import into nucleus
Regulation of cytokine production
Regulation of cytokine biosynthetic process
Regulation of interleukin 2 biosynthetic process
Regulation of immature T cell proliferation in thymus
Serine family amino acid catabolic process
Stress response to metal ion
Regulation of receptor internalization
Negative regulation of leukocyte adhesion to vascular endothelial cell
Regulation of membrane repolarization during action potential
Adenylate cyclase activating G protein-coupled receptor signaling pathway
DNA replication-dependent nucleosome assembly and organization
Common myeloid progenitor cell proliferation
Positive regulation of transcription from RNA polymerase III promoter
Negative regulation of megakaryocyte differentiation
Regulation of type B pancreatic cell proliferation
FOA2 and FOA3 transcription factor networks
Glucocorticoid receptor regulatory network
Alpha6 beta4 integrin ligand interactions
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potential and additional mechanism involved in skewing M1 
dim/M2 polarization of macrophages due to the fact that during 
the course of M2 polarization, macrophages get metabolically 
programmed to derive their metabolic energy through oxida-
tive phosphorylation which is known to suppress mitochondrial 
membrane potential (MMP) and mROS production. To clarify 
this, we used intra- as well as extracellular-unrelated bacteria 
like Mycobacterium smegmatis (Ms) and Escherichia coli (Ec) 
and expected their redundant impact on macrophage stimula-
tion. Unlike Chlamydia, stimulation of Ms- and Ec-infected 
macrophages with IFNγ enhanced the infection induced 
levels of NO synergistically at both 24 h and 48 h post infec-
tion (Figures S5A,B in Supplementary Material), confirming 





FigUre 2 | Continued
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FigUre 2 | Chlamydia pneumoniae-infected macrophages are refractory for immune stimulation. (a) Pulmonary titers of IL-10 in both WT-infected and uninfected 
mice were analyzed by sandwich ELISA. (B) IFNγ induced generation of NO by WT, and cpn-infected CD11b+/Gr-1 (−) peritoneal macrophage was quantified from 
the culture supernatants by the Griess reagent method. (c) Release of TNF in IFNγ-induced iNOS+ macrophages was quantified from both WT and xIAP KO by 
ELISA and (D) expression of iNOS proteins in CD11b+/Gr-1 (−) peritoneal macrophages from WT mice was confirmed by the immunofluorescence method upon 
stimulation with IFNγ for 24 h showing M1 polarization of these macrophages against control. In similar lines, TNF induced generation of NO by both WT and 
cpn-infected CD11b+/Gr-1 (−) peritoneal macrophage was quantified from the culture supernatants by the Griess reagent method (e) and the expression of iNOS 
proteins in CD11b+/Gr-1 (−) peritoneal macrophages from WT mice was confirmed by the immunofluorescence method upon stimulation with IFNγ for 24 h  
(F). IFNγ induced generation of NO by WT and xIAP KO (g) and TNF induced generation of NO by WT and cIAP KO upon infection with C. pneumoniae was 
quantified from the culture supernatants by the Griess reagent method (h). Statistical analysis was conducted either by using a two-tailed unpaired t-test and/or by 
using two-way ANOVA followed by Bonferroni post-test, respectively (*p < 0.05; **p < 0.01; and ***p < 0.001).
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smac Mimicry Promote anti-Bacterial 
response of naive Macrophages
During persistency, Chlamydia-infected cells display typical char-
acteristics of tumor cells and relay tumorigenic signals. Therefore, 
we argued whether their stimulation with Smac mimetic com-
pound: birinapant, a well-known IAP-specific inhibitor (26–28) 
known to boost immunity against various tumors, would revert 
refractory phenotype of infected macrophage. To this end, 
murine macrophage activation was analyzed upon treatment 
with birinapant. Birinapant enhanced constitutive levels of NO 
generation (Figure  3A) without influencing the expression of 
iNOS (Figures 3B,C) thus indicating its capability of skewing M1 
phenotype in naïve macrophages. This outcome could be either 
due to enhanced expression or release of mitochondrial NO syn-
thase along with SMAC Diablo which could have contributed for 
high NO titers by naïve macrophage. Birinapant treatment also 
downregulated AMPK/mTOR proteins and upregulated BAD/
GSK-3 pathways (Figure 3D) which are important for metabolic 
pathways, indicating immune metabolic programming of smac 
flushed macrophages. On the basis of these results, we presumed 
whether birinapant would enhance the defense mechanisms of 
macrophages. To demonstrate this, macrophages were infected 
with Ms and Ec followed by stimulation with IFNγ in the pres-
ence or absence of birinapant. Interestingly, treatment of infected 
macrophages with birinapant either alone or in combination with 
IFNγ enhanced infection-induced NO levels and bacterial kill-
ing capacity of macrophages significantly for Ms and transiently 
for Ec (Figures S5A–F and S6A,B in Supplementary Material), 
indicating the novel anti-bacterial characteristics of birinapant in 
line with its anti-tumor impact. Birinapant treatment enhanced 
IFNγ-induced expression of iNOS synergistically in infected 
cells (M1 proteins) at 48 h post infection time interval (Figures 
S6C,D in Supplementary Material) which was accompanied with 
the upregulating XIAP proteins. This indicated a compensation 
of XIAP in birinapant-exposed macrophages and suggested 
probable involvement of XIAP proteins in birinapant-induced 
anti-bacterial response in macrophages. On this basis, we argued 
whether birinapant would be able to maintain M1 effector 
phenotype in macrophage in response to Ld which drives M2 
polarization in macrophages. To test this, RAW macrophages 
were infected with Ld and analyzed for changes in NO titer 
during the course of infection as indicative of M1 phenotype. 
Unlike Ms/Ec infection and in line with C. pneumoniae infection, 
Ld infection not only reduced constitutive NO titers in these 
macrophages but also resisted the generation of NO upon their 
costimulation with Th1 cytokines (Figure S7 in Supplementary 
Material). Contrary to our prediction and unlike Ms/Ec infection, 
birinapant could neither influence Ld-induced NO levels over 
Ld control nor assisted IFNγ for boosting NO level over IFNγ 
control, indicating its redundancy for affording immunity in the 
macrophages infected with pathogenic microbes.
iaP Deficiency Promotes M2 Polarization 
of M1 effector Macrophages
On the basis of anti-bacterial nature of birinapant, we argued 
whether birinapant would enhance M1 phenotype further in 
Th1-primed macrophages or not. In contrast, birinapant treat-
ment inhibited M1 programming in LPS- and/or IFNγ-primed 
macrophages evidenced by significant inhibition in NO genera-
tion and reduction in the expression of key signaling, immune- 
and metabolism-related proteins in committed macrophages 
(Figures 4A–D). These results, in line with both our microarray 
and in vivo data, supported the involvement of IAPs in immune-
metabolic programming of committed macrophages indicating 
the M2 polarization of birinapant-treated macrophages. To 
further confirm this observation, PancO2 tumor cell-derived 
lysate was used for inducing M2 or tumor-associated phenotype 
in M1 macrophages (29), both in the presence and absence of 
birinapant. Tumor lysate-pulsed M1 macrophages produced 
minimal NO titers analyzed from their cell culture supernatants. 
Interestingly, NO titers were further put down upon treating 
tumor lysate-pulsed M1 macrophages with BP comparatively 
(Figure  5A). These observations were also accompanied with 
expected changes in iNOS and other key M1-associated pro-
teins like STAT-3, NF-κB, and phospho-p38MAPK and IAPs 
(Figures 5B–D) thus suggesting the temporal regulation of IAPs 
during polarization of macrophages.
During chronic inflammatory conditions, extreme hypoxia 
prevail manifesting in the stabilization of HIF-1 which is one 
of the decisive tissue specific factors that control macrophage 
mitochondrial functions during inflammatory. Our previous 
report has also identified HIF-1 stabilization during persistent 
infection with Chlamydia trachomatis persistency. Therefore, we 
anticipated that IAP deficiency might promote HIF-1-associated 
response in macrophages as well. To demonstrate this, iNOS+ 
macrophages were treated with CoCl2 (Cobalt chloride) for 
inducing the expression of HIF-1 (Figure S8 in Supplementary 
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FigUre 3 | Birinapant regulates phenotypic and immune-metabolic programming in naive macrophages. RAW264.7A murine MΦ was treated with and without 
birinapant and cultured for indicated time points. (a) NO titer was quantified in the culture supernatants by the Griess reagent method. (B) The cultures mentioned 
under (a) were lysed and analyzed for various M1 and M2 effector proteins, inhibitors of apoptosis proteins, and signaling markers by Western blotting. (c) The 
Western blots were quantified for densitometry by Image J software, and mean densitometry values of independent proteins were divided with its mean 
densitometry values of its respective β-actin band intensity value to present the relative expression of each protein as a mean in the ratio of protein to actin. (D) To 
monitor the intracellular signaling, important metabolic signaling component activation was observed using PathScan Intracellular Signaling Array Kit from Cell 
Signaling Technology. Images were analyzed by using ImageJ software, and mean densitometry values were plotted in terms of relative expression. Statistical 
analysis was conducted using two-way ANOVA followed by the Bonferroni post-test (*p < 0.05; **p < 0.01; and ***p < 0.001).
A
B
FigUre 4 | Continued
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innate immune and metabolism-related proteins were analyzed. 
CoCl2 treatment resulted in the increased production of NO and 
iNOS expression levels in naïve macrophages but inhibited the 
same in M1 macrophages (Figures S8A–E in Supplementary 
Material). Interestingly, birinapant treatment further reduced 
NO levels in CoCl2-treated M1 macrophages over CoCl2 
control and influenced innate immune and metabolic proteins 
and promoted HIF-1-induced M2 polarization. To confirm the 
impact of IAP on angiogenesis, which is sensed by VLH and 
executed by VEGF, one of the HIF-1 target proteins and which 
gets upregulated in M2 polarized macrophages for compensating 
O2 demand; effect of birinapant on VEGF-treated macrophages 
CD
FigUre 4 | Birinapant regulate M1 programming and immune-metabolic programming in lipopolysaccharide (LPS) and/or IFNγ-skewed iNOS+ macrophages. 
RAW264.7A murine MΦ was stimulated with Th1 cytokines LPS or IFNγ and both LPS and IFNγ with and without birinapant and cultured for indicated time points. 
(a) NO titer was quantified in the culture supernatants by the Griess reagent method. The data are represented as mean μM of NO ± SEM, and statistical analysis 
was conducted using two-way ANOVA followed by the Bonferroni post-test (*p < 0.05; **p < 0.01; and ***p < 0.001). (B) The cultures mentioned under (a) were 
lysed and analyzed for various M1 and M2 effector proteins, inhibitors of apoptosis proteins, and signaling markers by Western blotting. (c) The Western blots were 
quantified for densitometry by Image J software, and mean densitometry values of independent proteins were divided with its mean densitometry values of its 
respective β-actin band intensity value to present the relative expression of each protein as a mean in the ratio of protein to actin. (D) To monitor the intracellular 
signaling, important metabolic signaling component activation was observed using PathScan Intracellular Signaling Array Kit from Cell Signaling Technology. Images 
were analyzed by using ImageJ software, and mean densitometry values were plotted in terms of relative expression. Statistical analysis was conducted using 
two-way ANOVA followed by the Bonferroni post-test (*p < 0.05; **p < 0.01; and ***p < 0.001).
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was analyzed. Interestingly, VEGF stimulation has not altered 
constitutive NO levels significantly in comparison to control 
either in naïve or Th1-primed conditions. However, treatment 
with birinapant resulted in NO inhibition significantly while 
influencing signaling and metabolism-related proteins (Figures 
S9A–D in Supplementary Material). These cell line-based results 
provoked us to confirm the same in mouse primary macrophages. 
For that purpose, purified CD11b+/Gr-1 negative peripheral 
macrophages from mice were treated with either CoCl2 or VEGF 
and subsequently analyzed for NO titers by these macrophages 
AB
FigUre 5 | Continued
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in naïve or Th1-primed conditions upon treatment with/without 
birinapant (Figure S10 in Supplementary Material). In line with 
our in vitro data, treatment of these macrophages with VEGF/
COCl2 alone or in combination inhibited IFNγ-induced NO titer 
slightly in naïve (Figure S10A in Supplementary Material) but 
significantly in M1-differentiated macrophages (Figure S10B 
in Supplementary Material). This was reduced further upon 
costimulation of these macrophages with birinapant, while prov-
ing the involvement of IAPs in VEGF/hypoxia-driven M1 dim 
polarization in mouse primary macrophages.
smac Mimicry Promotes Wound healing 
Potential in Polarized Macrophages
M2 macrophages are potentially refractory and bear wound 
healing capacity. On the basis of M2 polarization of IAP-deficient 
macrophages, wound healing or angiogenic potential of IAPs 
in macrophages in the presence and absence of birinapant was 
analyzed. For this purpose, CD11b+/Gr-1 (−) peripheral mac-
rophages from healthy donors were isolated, purified, and cultured 
for 4 days in the presence of G-CSF-rich medium to allow their 
maturation. These cells were stimulated with LPS with and with-
out birinapant. Their conditioned media were collected 24 h post 
treatment and used as a source of various cytokine/growth factor 
secreted by these macrophages during polarization. Monolayer 
of HeLa cells was used for analyzing the wound healing potential 
of birinapant under the influence of macrophage-conditioned 
media. Birinapant alone or in combination with VEGF promoted 
wound healing in the HeLa cells providing an evidence for wound 
healing, angiogenic potential of Smac-mimetics (Figures 6A,B). 
Interestingly, the extent of wound healing of HeLa cells treated 
with birinapant directly or the condition media obtained from 
birinapant-pulsed macrophages remained comparable suggest-
ing that IAPs not only control macrophages polarization but also 
angiogenic potential of the macrophages (Figures 6C,D).
CD
FigUre 5 | Inhibitor of apoptosis proteins (IAP) regulates tumor lysate mediated sterile inflammatory responses and immune-metabolic programming in iNOS+ 
macrophages. (a) RAW264.7A murine MΦ was stimulated with Th1 cytokines lipopolysaccharide (LPS) or IFNγ and both LPA and IFNγ with and without lysate 
prepared from PancO2 pancreatic tumor cell line (100 ng protein) and birinapant and cultured for indicated time points. NO titer was quantified in the culture 
supernatants by the Griess reagent method. Shown here is the mean μM of NO ± SEM from three independent experiments. Statistical analysis was conducted using 
two-way ANOVA followed by Bonferroni post-test (***p < 0.001). (B) The cultures mentioned under A were lysed and analyzed for various M1 and M2 effector proteins, 
IAPs, and signaling markers by Western blotting. (c) The Western blots were quantified for densitometry by Image J software, and mean densitometry values of 
independent proteins were divided with its mean densitometry values of its respective β-actin band intensity value to present the relative expression of each protein as  
a mean in the ratio of protein to actin. (D) To monitor the intracellular signaling, important metabolic signaling component activation was observed using PathScan 
Intracellular Signaling Array Kit from Cell Signaling Technology. Images were analyzed by using ImageJ software, and mean densitometry values were plotted in terms  
of relative expression. Statistical analysis was conducted using two-way ANOVA followed by Bonferroni post-test (*p < 0.05; **p < 0.01; and ***p < 0.001).
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FigUre 6 | Inhibitors of apoptosis proteins regulate wound healing efficiency of primary macrophages. (a) HeLa cells at 2.5 × 104 per well in 24-well plates cultured 
in complete RPMI medium for 24 h at 37°C to form a cell monolayer before the wound was made by a scratch. HeLa cells were allowed to migrate for 24 h upon 
treating with and without BP and vascular endothelial growth factor, respectively. Images of the wound areas were captured using an Inverted Fluorescence 
Microscope, at 10× and compared with images taken immediately after scratch was made. (B) Wound area was quantified by analyzing the images using ImageJ, 
and the percentage closure of the wound area was plotted as mean ± SE. (c) HeLa cells described in (a) were cultured in media conditioned by primary 
macrophages stimulated with lipopolysaccharide (LPS) (CM1) and/or in media conditioned by primary macrophages stimulated with LPS and treated with birinapant 
(CM2). Images of the wound areas were captured using an Inverted Fluorescence Microscope, at 10× and compared with images taken immediately after scratch 
was made. (D) Wound area was quantified by analyzing the images using ImageJ, and the percentage closure of the wound area was plotted as mean ± SE. 
Images presented are the representative of three independent experiments done in triplicates. Statistical analysis was conducted using two-way ANOVA followed  
by the Bonferroni post-test (*p < 0.05 and **p < 0.01).
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Deficiency of iaPs Promote immune 
Metabolic Programming in Macrophages
M1 or committed macrophages, during their encounter with 
pathogens, rely on glucose-induced glycolytic and Warburg 
reactions, deriving energy for performing various immune 
related functions. In contrast, M2-differentiated macrophages 
perform their function on the energy provided by oxidative 
phosphorylation which fuel polarized macrophages at much 
A B
FigUre 7 | Inhibitors of apoptosis protein reprogram metabolic activity in both naive and Th1-primed macrophages during macrophage polarization. Naïve and 
Th1-primed RAW264.7A murine MΦ with (a) Naïve and (B) Th1 primed RAW264.7A murine MΦ (M1; iNOS+) were treated with metformin and cultured in both 
normal and high glucose condition in the presence and absence of birinapant and cultured for indicated time points. NO titer was quantified in the culture 
supernatants by the Griess reagent method. Data shown here is ±SEM from three independent experiments. Statistical analysis was conducted using two-way 
ANOVA followed by the Bonferroni post-test (*p < 0.05; **p < 0.01; and ***p < 0.001).
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lower rate compared to glycolytic pathways. As it is quite evi-
dent that immune metabolism is decisive for their functional 
plasticity, the functional role of IAP in immune metabolic 
programming of macrophages was analyzed. Smac Diablo is a 
mitochondrial protein with active involvement of mitochondria 
in both immunity and metabolism, we anticipated for birina-
pant-mediated metabolic reprogramming of macrophages and 
found that birinapant downregulated AMPK/mTOR pathways 
while upregulating BAD/GSK-3 pathways in macrophages. 
On this basis, it was rationale to presume that IAPs other than 
controlling cell death and immunity also play a decisive role in 
cellular metabolism in macrophages. To confirm this hypoth-
esis, both naïve and iNOS+ M1 macrophages were treated with 
different concentrations of glucose and analyzed the glucose 
treatment effect on NO generation as indicative of M1 polariza-
tion and metabolic activities in macrophages. Culturing naïve 
macrophages with high glucose over normal glucose contain-
ing medium not only enhanced NO levels but also enhanced 
their metabolic activities while conferred M1-like phenotype, 
similar to the phenotype of macrophages from diabetic patients 
(Figures  7A,B). Most interestingly, treatment of high glucose 
fed macrophages with birinapant reduced both NO levels and 
metabolic activities (Figure S11 in Supplementary Material) in 
these cells significantly indicating disruption of M1 signature by 
targeting IAP. On the basis of birinapant-driven downregula-
tion of AMPK, we anticipated that birinapant may improve the 
action of metformin which also inhibits AMPK. To address our 
hypothesis, macrophages were treated with metformin alongside 
birinapant treatment in both low and high glucose conditions. 
Although the treatment of naïve macrophages with metformin 
did not influence the levels of NO in these macrophages when 
cultured in normal glucose conditions, the same inhibited NO 
titer significantly in the macrophages cultured in high glucose 
containing medium (Figure 7A). NO levels in metformin-treated 
group remained comparable to birinapant-treated macrophages. 
Interestingly, and unlike naïve macrophages, exposing iNOS+ 
macrophages to metformin strongly inhibited IFNγ-induced 
NO levels (Figure 7) which were further reduced by birinapant. 
Interestingly, compared with naïve macrophages, birinapant 
remained more effective in Th1-primed cells in breaking down 
the M1 phenotype. Thus, these results revealed for the first time 
the involvement of IAPs in immune-related metabolism.
DiscUssiOn
Host cell apoptosis is vital for orchestrating optimum immune 
response against microbes and tumors. In this study, we discussed 
and provided a mechanism explaining how dysregulation of 
apoptosis can jeopardize the immune response of macrophages. 
Macrophages are unique and display both phenotypical and 
functional plasticity enabling them to perform a wide range of 
functions ranging from immune to physiological roles includ-
ing tissue homeostasis. During pathogen encounter and other 
inflammatory assaults, these cells get exposed to various stresses 
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where cells require high metabolic index to encounter the 
same while maintaining optimum immune response. M1 mac-
rophages are highly metabolic in nature which utilized glucose 
as their main source of energy. These macrophages produce 
many mediators via glycolytic pathways and promote Warburg 
reactions which directly or indirectly help in controlling infec-
tion while impacting on the phenotypic plasticity of inflam-
matory macrophages in diseased conditions (30, 31). Here, we 
demonstrate that IAPs are novel proteins which can dictate both 
functional plasticity and metabolic activities of macrophages 
during both bacterial encounter and inflammation-related 
stress conditions. Pathogens like Chlamydiae, which depend 
upon IAPs, hijack the plastic nature and mitigate immune 
and metabolic activities in inflammatory macrophages for 
their own benefits. Under certain pathological circumstances 
manifested by high IFNγ, these bacteria undergo persistency. 
This is accompanied with catabolism of tryptophan which is 
decisive for the metabolic activity of macrophages, deficiency 
of which is known to enhance immune tolerance directly and 
reduced mitochondrial functions indirectly. IFNγ-mediated 
persistency via activating indoleamine 2,3-dioxygenase deplete 
cellular depot of tryptophan thus further contributing for the 
induction of RB conversion to EB, the form in which the bacte-
ria resist various antibiotic treatments. Similarly, upregulation 
of MAPK14 by Chlamydiae infection in host cells seems to 
be another mechanism by which these bacteria could disrupt 
effecter phenotype of macrophages (32). Upregulation of 
MAPK14 proteins inhibit the expression of iNOS while upregu-
lating the expression of Arginase-1 proteins (33, 34) which are 
associated with M2 polarization of macrophages during para-
sitic infection (35) and bacterial sepsis (36). Other than this, 
upregulation of MAPK (particularly p38MAPK) promotes the 
shedding of TNFR1 and it is quite likely that in the absence of 
TNFR1, either upregulation or shift toward TNFR2-associated 
pathways like PI-3K/pAKT/p38MAPK pathways could also 
have contributed to M2 polarization of effector macrophages. In 
similar lines, internalization of TNFR1 in infected macrophages 
could have contributed for infection mediated blocking of 
NO in TNF-primed macrophages. During persistency, these 
bacteria release type 3 secretions like HSP60 which interact 
with various signaling or metabolic pathways including aerobic 
respiration and oxidative metabolism in the host cells including 
macrophages (35, 37, 38). HSP60 is responsible for majority of 
immunopathological damage during the infection (39), and 
among those stabilization/upregulation of HIF-1 (32, 36) in 
the infected host cells is one major mechanism by which these 
bacteria could suppress Th1 immune response and regulate the 
activity of iNOS+ M1 macrophages (32). Hypoxic environment 
is known to jeopardize the anti-bacterial defense potential of 
macrophages (40) and inhibits mitochondrial respiratory chain 
functions and impair metabolic activities which are essential for 
killing of several bacterial pathogens including C. pneumoniae 
(41, 42) by professional phagocytes like macrophages. Other 
than this, HSP60 from C. pneumoniae is also responsible for 
foamy transformation of inflammatory macrophages (43, 44), 
which are having unusual pro-inflammatory signaling due to 
constitutive upregulation of PPAR signaling and accumula-
tions of certain lipids like cholesterol and/or sphingolipids in 
macrophages (20, 45–48). Therefore, it is quite possible that 
accumulated HSP60 in infected XIAP KO lung could have 
skewed M2 polarization in XIAP KO-infected macrophages, 
rendering them metabolically inactive and poor in anti-bacterial 
defenses.
Although several cells of immune system other than mac-
rophages like granulocytes, neutrophils and B cells constitute the 
innate immunity, macrophages are capable of controlling T cells 
immune response and thus contribute to adaptive immunity as 
well (49). Therefore, in this study, we mainly analyzed the impact 
of birinapant on macrophages particularly. However, we cannot 
overlook the impact of birinapant on other immune cells also in 
the course of reducing inflammatory reactions in animal models. 
From our data, it is also clear that increase in the metabolic activ-
ity of host, other than immune stimulation would certainly be 
paramount for the effective management of persistent infection 
and associated idiopathic diseases. In summary, our data dem-
onstrated birinapant-mediated immune metabolic programming 
of M1 macrophages during their encounter with bacteria and/
or sterile inflammatory stimulus. Thus, our study also suggests 
that the birinapant could be used as a drug candidate for control-
ling infection/inflammatory diseases which depend upon the 
macrophages.
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FigUre s1 | (a–e) cIAP1 proteins regulate TNF-mediated immune response in 
macrophages. mRNA from cIAP-1 WT and KO macrophages stimulated with TNF 
for 24  h duration was analyzed by whole mouse genome 44  k microarray Kit, 
Agilent technology (Cat No—G4122F, Chip ID no. 014868). Pathway-Express (PE) 
was used to map differentially expressed genes and Gene Spring 12.6.1 software 
(Agilent Technologies, Santa Clara, CA, USA) was used to prepare corresponding 
heat map. Pathways that were up/downregulated during TNF induction and or 
CIAP-KO were identified using previously developed method on Gene-Set enrich-
ment analysis. Genes Sets for mouse were downloaded from Bader lab and were 
obtained by translation of human counterparts using orthologous relationship from 
homologene database. (a) The representation of up- and downregulated total 
number of genes by cIAP-1 in macrophages in the form of Venn diagram while 
(B) are the gene sets from Reactome_3 pathways, (c) from BP_3.5 pathways, 
and (D) from NCL_2 pathways and gene ontology process from Mouse Genome 
Database (MGD).
FigUre s2 | Chlamydia pneumoniae infection induced sTNFR1 shedding in 
TNF-stimulated HeLa. cIap1 KO upon infection with C. pneumoniae and further 
stimulation with TNF was quantified at defined time intervals. Normal, cIAP1 
shRNA transfected, and vector control stable HeLa cells clones were infected with 
C. pneumoniae for one infection cycle and soluble/shed TNFR1 were quantified in 
their culture supernatant by sandwich ELISA method (Bio-Sources). Data are SE 
from two independent ± represented as picograms per milliliter of sTNFR1 released 
experiments. Statistical analysis was conducted using two-way ANOVA followed 
by Bonferroni posttest (*p < 0.05; **p < 0.01; ***p < 0.001).
FigUre s3 | Chlamydia pneumoniae interfere with iron mediate nitric oxide 
generation in macrophages. CD11b+/Gr-1ˉ peritoneal macrophages from WT, 
cIAP KO mice (a) and xIAP KO mice (B) were infected with C. pneumonia and 
stimulated with SNP (sodium nitroprusside), which release NO (nitric oxide) in 
iron-dependence manner. NO titers were quantified in their culture supernatant at 
indicated time interval. Data represented as mean of micrometers of NO ± SE and 
statistical analysis was conducted using two-way ANOVA followed by Bonferroni 
posttest (***p < 0.001).
FigUre s4 | IAP deficiency promotes Chlamydia pneumoniae-mediated interfer-
ence of macrophage stimulation and their metabolic activity. (a) WT, cIAP KO, and 
xIAP KO macrophages were infected with C. pneumoniae and the fate of altered 
metabolic activity in these macrophages at specified time points was analyzed 
by MTT assay. In similar lines, C. pneumoniae infection mediated altercations in 
metabolic activity of IFNγ (B), TNF (c), and SNP (D) stimulated macrophages were 
also quantified. Statistical analysis was conducted using two-way ANOVA followed 
by Bonferroni posttest (***p < 0.001).
FigUre s5 | Smac mimicry enhances Mycobacterium smegmatis/Escherichia coli 
infection-induced NO production macrophages. RAW 264.7 macrophages were 
infected with M. smegmatis/E. coli and after 1 h postinfection extracellular bacteria 
washed off and cells +BP.γ or BP and combination of IFNγ co-stimulated either 
with IFN NO production by these macrophages was quantified in cell supernatant 
at 24 h (a) and 48 h (B) postinfection. Bacterial counts (colony-forming unit per 
milliliters) were measured in macrophage cell lysates at 24  h (c,D) and 48  h 
postinfection (e,F). Data are represented as mean ±  SE of three independent 
experiments in triplicates and statistical analysis was conducted using Student’s 
t-test (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).
FigUre s6 | Mycobacterium smegmatis and Escherichia coli do not interfere with 
IFNγ-induced iNOS production in macrophages. RAW 264.7 macrophages were 
infected with M. smegmatis and E. coli and stimulated either with/without IFNγ 
and/or BP and expression of iNOS in these whole cell lysates were analyzed by 
Immunoblotting at 24 h (a,B) and 48 h (c,D) postinfection. Data shown are the 
representative of three independent repeats and the densitometry analysis of the 
representative blots was done using ImageJ and presented as ratio of proteins 
with actin.
FigUre s7 | Leishmania donovani skew M2 phenotype in macrophages and 
interfere with IFNγ-stimulated generation of NO in macrophages. RAW 264.7 
macrophages were infected with L. donoveni (MOI-5) and, after 4 h, the extra-
cellular parasites were washed off. Macrophages were stimulated with IFNγ 
and treated with BP while maintaining untreated cells as controls. NO titres 
were quantified in cell culture supernatant at 24 and 48 h postinfection. Data 
presented are mean of three independent experiments done in triplicates and 
statistical analysis was conducted using Student’s t-test (*p < 0.05; **p < 0.01; 
***p < 0.001).
FigUre s8 | IAP regulates hypoxic-mediated sterile inflammatory responses in 
iNOS+ macrophages. RAW macrophages were cultured in presence of CoCl2 and 
the expression of iNOS and HIF1 proteins was analyzed by immunofluorescence 
(a) for confirming M1 polarization of these macrophages. RAW264.7A murine MΦ 
were stimulated with Th1 stimuli viz LPS or IFNγ and both LPA and IFNγ with 
and without CoCl2 and Brinapant and cultured for indicated time points. (B) NO 
titer was quantified cell culture supernatants and the data were represented as a 
mean micrometers of NO ± SEM. Statistical analysis was conducted using one 
way ANOVA followed by Bonferroni posttest (*p < 0.05; **p < 0.01; ***p < 0.001). 
(c) The cultures mentioned under (B) were lysed and analyzed for various M1 
and M2 effector proteins, IAPs and signaling markers by western blotting. (D) 
Densitometry quantification of western blots from three independent repeats were 
analyzed by Image J and the data were plotted as mean of protein/actin ratio (e). 
To monitor the intracellular signaling, important metabolic signaling component 
activation was observed using PathScan Intracellular Signaling Array Kit from Cell 
Signaling Technology. Images were analyzed by using ImageJ software and mean 
densitometry values were plotted in terms of relative expression. Statistical analysis 
was conducted using two-way ANOVA followed by Bonferroni posttest (*p < 0.05; 
**p < 0.01; ***p < 0.001).
FigUre s9 | IAP regulates angiogenic programming in iNOS+ macrophages. 
RAW264.7A murine MΦ were stimulated with Th1 stimuli viz LPS or IFNγ and 
both LPS or IFNγ with and without VEGF and Brinapant and cultured for indi-
cated time points. (a) NO titer was quantified in the cell culture supernatant and 
the data was represented as the mean micrometers of NO ± SEM. Statistical 
analysis was conducted using one-way ANOVA followed by Bonferroni posttest 
(*p  <  0.05; **p  <  0.01; ***p  <  0.001). (B) The cultures mentioned under (a) 
were lysed and analyzed for various M1 and M2 effector proteins, IAPs, and 
signaling markers by western blotting. (c) Densitometry quantification of western 
blots from three independent repeats were analyzed by Image J and the data 
were plotted as mean of protein/actin ratio. (D) To monitor the intracellular 
signaling, important metabolic signaling component activation was observed 
using PathScan Intracellular Signaling Array Kit from Cell Signaling Technology. 
Images were analyzed by using ImageJ software and mean densitometry values 
were plotted in terms of relative expression. Statistical analysis was conducted 
using two-way ANOVA followed by Bonferroni posttest (*p < 0.05; **p < 0.01; 
***p < 0.001).
FigUre s10 | IAP control hypoxia induce polarization in Th1 committed CD11b+ 
mouse peripheral macrophages. CD11b+ peritoneal macrophages were purified 
by MACS-based method and cultured o/n and stimulated with VEGF and CoCl2 
in presence of Brinapant. NO titres were quantified in both naïve (a) and IFNγ-
stimulated (B) macrophages. Shown here is the mean micrometers of NO ± SEM 
from three independent experiments.
FigUre s11 | IAP proteins re-program metabolic activity in both naive and 
INOS+ macrophages during macrophage polarization. RAW264.7A murine MΦ 
either naïve (a) or stimulated with Th1 effector cytokine IFNγ (B); were treated 
with metformin in both normal and high glucose condition and in presence and 
absence of Brinapant and cultured for indicated time points. NO titer was quantified 
and the data represent the mean micrometers of NO ± SEM. Statistical analysis 
was conducted using two-way ANOVA followed by Bonferroni posttest (*p < 0.05; 
**p < 0.01; ***p < 0.001).
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